Value of neuropsychological tests to identify patients with depressive symptoms on the Alzheimer’s disease continuum

Manuscript Number: 

20-0710R2

Author(s): 
Chris Bauer, Silka Dawn Freiesleben, Manuel Fuentes-Casaña, Arne Klostermann, Felix Menne, Oliver Peters, Carola G. Schipke

Disclosures

Chris Bauer

  • Nothing to Disclose

Silka Dawn Freiesleben

  • Nothing to Disclose

Manuel Fuentes-Casaña

  • Nothing to Disclose

Arne Klostermann

  • Nothing to Disclose

Felix Menne

  • Nothing to Disclose

Oliver Peters

  • Consulting Fees:
    Biogen, Roche
    Lecture Fees:
    Roche
    Grants
    • Agency: 
      Biogen
      Dates: 
      2016-2020
    • Agency: 
      Roche
      Dates: 
      2017-2020
    • Agency: 
      Novartis
      Dates: 
      2018-2019
    • Agency: 
      Janssen
      Dates: 
      2017-2019
    • Agency: 
      Pharmatrophix
      Dates: 
      2017-2020
    • Agency: 
      Eisai
      Dates: 
      2020

Carola G. Schipke

  • Patents/Royalties
    CGS is an inventer on patent WO2017190834A8